[Vaccination of premature infants, a population at high risk of infection]

Revue Medicale De Bruxelles
|November 24, 2015
PubMed

Insights

Premature infants can mount effective immune responses to vaccines, but close monitoring for transient cardiorespiratory events is crucial. This review outlines current immunization guidelines for premature infants.

Area of Science:

  • Neonatal Medicine
  • Immunology
  • Pediatrics

Background:

  • Prematurity incidence is rising in Belgium, with infections posing significant risks to infants.
  • Infections contribute to morbidity and mortality in premature infants during hospitalization and post-discharge.
  • Despite immune system immaturity, premature infants can develop protective responses to most vaccines.

Purpose of the Study:

  • To review current immunization recommendations for premature infants.
  • To address concerns regarding vaccine safety in this vulnerable population.

Main Methods:

  • Literature review of current vaccination guidelines and studies on premature infant immunization.
  • Analysis of risks and benefits of vaccination in premature infants.

Main Results:

  • Premature infants demonstrate an ability to develop protective immune responses to vaccines.
  • Transient cardiorespiratory events may occur post-vaccination in unstable very low birth weight infants.
  • These events are generally transient and without long-term consequences with proper monitoring.

Conclusions:

  • Vaccination is recommended for premature infants.
  • Close monitoring during and after vaccination is essential for managing potential transient adverse events.
  • Adherence to updated immunization schedules is vital for protecting premature infants from infections.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
53.7K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
42
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
744